| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-15 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-13 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |